首页> 美国卫生研究院文献>Oxford Open >1972. Safety and Immunogenicity of 15-Valent Pneumococcal Conjugate Vaccine (PCV-15) Compared with PCV-13 in Healthy Older Adults Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23)

【2h】

1972. Safety and Immunogenicity of 15-Valent Pneumococcal Conjugate Vaccine (PCV-15) Compared with PCV-13 in Healthy Older Adults Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23)

机译：1972年。在以前接种过23价肺炎球菌多糖疫苗（PPV23）的健康老年人中15价肺炎球菌结合疫苗（PCV-15）与PCV-13的安全性和免疫原性。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundSafety and immunogenicity of a new formulation of PCV-15 (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19F, 19A, 22F*, 23F, 33F*) was evaluated in adults ≥65 years of age previously vaccinated with PPV23.

机译：背景对≥65岁的成年人评估了PCV-15新制剂（1、3、4、5、6A，6B，7F，9V，14、18C，19F，19A，22F *，23F，33F *）的安全性和免疫原性以前已接种PPV23的婴儿年龄。

著录项

期刊名称 Oxford Open
作者
Ulrike Buchwald; James Peterson; Helen Stacey; Katie Julien; Tina Sterling; Melanie Bruch; Gretchen Tamms; Jianing Li; Alison Pedley; Katrina Nolan; Patrice Benner; Chitrananda Abeygunawardana; Michael Winters; Michael Kosinski; Jon Stek; Luwy Musey;
展开▼
作者单位

展开▼
年(卷),期 -1(5),Suppl 1
年度 -1
页码 S572
总页数 1
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine compared to 13-valent pneumococcal conjugate vaccine in adults >= 65 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine [J] . Peterson James T., Stacey Helen L., MacNair John E., Human vaccines & immunotherapeutics. . 2019,第3期

机译：15价肺炎球菌缀合物疫苗的安全性和免疫原性与成人中的13价肺炎球菌缀合物疫苗> = 65岁以前用23价肺炎球菌多糖疫苗接种疫苗
2. Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adults [J] . Stacey Helen L., Rosen Jeffrey, Peterson James T., Human vaccines & immunotherapeutics. . 2019,第3期

机译：与健康老年人的PCV-13相比，15价肺炎球菌缀合物疫苗（PCV-15）的安全性和免疫原性
3. Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults [J] . Jackson Lisa A., Gurtman Alejandra, van Cleeff Martin, Vaccine . 2013,第35期

机译：在未接种肺炎球菌疫苗的成年人中，与23价肺炎球菌多糖疫苗相比，13价肺炎球菌结合疫苗的免疫原性和安全性
4. Decision-Tree Model for Support of Health Policy Choices Based on Pneumococcal Conjugate Vaccine (PCV) Program Outcomes [C] . Andre Cohen, Casimir A. Kulikowski, Timothy Elbert, MEDINFO . 2017

机译：基于肺炎球菌共轭疫苗（PCV）计划结果的卫生政策选择支持决策树模型
5. Response to Pneumococcal-Polysaccharide Vaccine PPV23 in HIV-Positive Individuals [D] . Iyer, Anita Sridhar. 2015

机译：HIV阳性人群对肺炎球菌多糖疫苗PPV23的反应
6. Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine compared to 13-valent pneumococcal conjugate vaccine in adults ≥65 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine [O] . James T. Peterson, Helen L. Stacey, John E. MacNair, 2019

机译：15价肺炎球菌结合疫苗与13价肺炎球菌结合疫苗相比在先前接种过23价肺炎球菌多糖疫苗的65岁以上成年人中的安全性和免疫原性
7. 1972. Safety and Immunogenicity of 15-Valent Pneumococcal Conjugate Vaccine (PCV-15) Compared with PCV-13 in Healthy Older Adults Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) [O] . Ulrike Buchwald, James Peterson, Helen Stacey, 2018

机译：1972年。与以前用23价肺炎球菌多糖疫苗接种的健康老年人（PPV23）的健康老年人的PCV-13相比，15价肺炎球菌缀合物疫苗（PCV-15）的安全性和免疫原性。

1972. Safety and Immunogenicity of 15-Valent Pneumococcal Conjugate Vaccine (PCV-15) Compared with PCV-13 in Healthy Older Adults Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23)

摘要

著录项

相似文献

相关主题

期刊订阅